In July 2024, researchers in China reported a novel GNAI3 gene mutation in a family affected by ACS and demonstrated successful treatment of dentofacial deformities using 3D-guided distraction osteogenesis combined with orthodontics, achieving normal facial function at 5‑year follow-up
